Identification of a Single-Nucleotide Polymorphism within <i>CDH2</i> Gene Associated with Bone Morbidity in Childhood Acute Lymphoblastic Leukemia survivors

Abstract

<b>Aim:</b> To identify genetic markers associated with late treatment-related skeletal morbidity in survivors of childhood acute lymphoblastic leukemia (ALL). <b>Patients & methods:</b> To this end, we measured the association between reduction in bone mineral density or vertebral fractures prevalence and variants from 1039 genes derived through whole exome sequencing in 242 childhood ALL survivors. Top-ranking variants were confirmed through genotyping, and further explored with stratified analyses and multivariable models. <b>Results:</b> The minor allele of rs1944294 in <i>CDH2</i> gene was associated with bone geometrical parameter, trabecular cross-sectional area (p = 0.001). The association was modulated by radiation therapy (p = 0.001) and post-treatment time (p = 0.0002). <b>Conclusion:</b> The variant in <i>CDH2</i> gene is a potential novel risk factor of bone morbidity in survivors of childhood ALL.